Effect of Phonophoresis on Trigger Points

September 30, 2026 updated by: Reem Dawood, Batterjee Medical College

purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

participants will be divided into 3 groups, 2 study groups and 1 control group.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
      • Jeddah, Saudi Arabia
        • Batterjee Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • upper trapezius trigger point

Exclusion Criteria:

  • cervical disc

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: study Fastum

participant in this group will receive US with fastum gel
Other: US with fastum

apply fastum on trigger point with US
Experimental: study Reparil

participant in this group will receive US with reparil gel
Other: US with reparil

apply reparil on trigger point with US
Active Comparator: Control plain gel

participant in this group will receive US with gel
Other: US with plain gel

apply gel on trigger point with US

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: Two weeks and 3 months follow up

change of pain intensity by using VAS from 0 to 10
Two weeks and 3 months follow up
pain threshold
Time Frame: two weeks and 3 months follow up

change of pain threshold by using PPA
two weeks and 3 months follow up
ROM
Time Frame: two weeks and 3 months follow up

change of ROM by using CROM
two weeks and 3 months follow up
neck function
Time Frame: Two weeks and 3 months follow up

change of neck function by using Neck Disability Index (NDI) questionnaire
Two weeks and 3 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Batterjee Medical College

Investigators

  • Study Director: Osama R Abdelraouf, PhD, Batterjee Medical College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

December 30, 2023

Study Registration Dates

First Submitted

June 13, 2023

First Submitted That Met QC Criteria

June 22, 2023

First Posted (Actual)

June 29, 2023

Study Record Updates

Last Update Posted (Actual)

October 1, 2026

Last Update Submitted That Met QC Criteria

September 30, 2026

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Phonophoresis

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

all data are secured with principle investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe